Brain Protein Blamed for Hypertension
Posted on: Monday, 16 April 2007, 18:00 CDT
British medical scientists have determined one cause of high blood pressure might involve a brain protein.
The controversial idea was put forward by Hidefumi Waki at the University of Bristol. Waki, working in a research group led by Professor Julian Paton, has found a novel role for the protein, JAM-1 (junctional adhesion molecule-1), which is located in the walls of blood vessels in the brain.
JAM-1 traps white blood cells called leukocytes which, once trapped, can cause inflammation and may obstruct blood flow, resulting in poor oxygen supply to the brain. That has led to the idea that high blood pressure might be an inflammatory vascular disease of the brain.
We are looking at the possibility of treating those patients that fail to respond to conventional therapy for hypertension with drugs that reduce blood vessel inflammation and increase blood flow within the brain, said Paton. The future challenge will be to understand the type of inflammation within the vessels in the brain, so that we know what drug to use, and how to target them. JAM-1 could provide us with new clues as to how to deal with this disease.
The research is published in the journal Hypertension.
Source: United Press International
Related Articles
- Scientists Use Blood-Brain Barrier As Therapy Delivery System
- Nanoparticles Cross Blood-brain Barrier To Enable 'Brain Tumor Painting'
- Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier
- Blood Test For Brain Injuries Gains Momentum
- GEN Reports On Strategies To Overcome Blood-Brain Barrier
- GEN Reports on Strategies to Overcome Blood-Brain Barrier
- ImaRx Therapeutics to Study Permeability of Blood-Brain Barrier Using Microbubbles & Ultrasound Under NIH Grant
- Amarin Corporation Plc Reports Miraxion Improves Stress Hormone Transport Through the Blood Brain Barrier in Pre-Clinical Studies
- Cancer Fighter Gets Past Blood-Brain Barrier
- Characterization of a ^Sup 67^Ga/^Sup 68^Ga Radiopharmaceutical for SPECT and PET of MDR1 P-Glycoprotein Transport Activity In Vivo: Validation in Multidrug-Resistant Tumors and at the Blood-Brain Barrier
User Comments (0)

RSS Feeds